{
  "id": 692320,
  "title": "Kenya, Pfizer explore expanded health and investment partnership",
  "url": "https://urgent.news/2026/08/12/kenya-pfizer-explore-expanded-health-and-investment-partnership",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-12T18:56:32.000Z",
  "source": {
    "name": "KBC",
    "slug": "kbc",
    "url": "https://www.kbc.co.ke/kenya-pfizer-explore-expanded-health-and-investment-partnership/"
  },
  "original_language": "en",
  "account": "Kenya and Pfizer have extended their collaboration in healthcare and investment, as revealed during a recent meeting between Kenya's Principal Secretary for Medical Services, Dr. Ouma Oluga, and Pfizer's Vice President for Access and Accord in Emerging Markets, Ali Besri. The meeting, held on Wednesday, marked a review of the Ministry of Health-Pfizer Overseas LLC Memorandum of Understanding (MoU), which will now focus on not-for-profit access to Pfizer's medicines and vaccines, supply-chain strengthening, regulatory collaboration, and health workforce development.\n\nDr. Oluga emphasized the need for the partnership to expand beyond mere access to medicines, calling for a broader strategic collaboration that includes clinical trials, research, technology transfer, local manufacturing, and Kenya's potential role as a logistics and distribution hub for East Africa. This proposal aligns with Kenya's Health Products and Technologies Local Manufacturing Strategy 2026-2030, which aims to bolster pharmaceutical manufacturing, research, regulation, and regional distribution while ensuring affordable access to essential and innovative health products.\n\nThe meeting also highlighted the importance of operationalizing the Joint Coordination Committee established under the MoU. The Committee, comprised of representatives from the Ministry, Pfizer, the Pharmacy and Poisons Board, Kenya Medical Supplies Authority, and other relevant government agencies, will oversee implementation, monitor progress, and coordinate engagement among the various stakeholders. The MoU, initially signed in April 2025 and renewed in May 2026, demonstrates Kenya and Pfizer's shared commitment to advancing healthcare in the region.",
  "summary": "Kenya has strengthened its partnership in vaccination and access to medicine following a review on the implementation of the Ministry of Health–Pfizer Overseas LLC Memorandum of Understanding (MoU). The agreement witnessed on Wednesday by Principal Secretary for Medical Services Dr. Ouma Oluga and Pfizer Biopharmaceuticals Group Vice President for Access and Accord in Emerging Markets, […] The…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}